What is Doctor At Work?
Established in 2009, Doctor At Work operates as a leading digital communication platform designed to foster effective interaction between healthcare professionals and pharmaceutical companies. The company provides a comprehensive suite of tools, including webinars, display ads, and social media engagement, specifically tailored for doctors and pharmacists. With a robust user base exceeding 480,000 verified doctors across 103 specialties in Russia, Doctor At Work offers invaluable insights and analytics crucial for pharmaceutical marketing strategies. Its innovative approach and extensive database of healthcare professionals have earned the trust of major pharmaceutical entities, positioning it as a key player in the digital health communication landscape.
How much funding has Doctor At Work raised?
Doctor At Work has raised a total of $5.8M across 2 funding rounds:
Unspecified
$3M
Unspecified
$2.8M
Unspecified (2014): $3M with participation from Bright Capital Digital Fund, Guard Capital, and The Aurora Funds
Unspecified (2014): $2.8M led by Guard Capital
Key Investors in Doctor At Work
Bright Capital Digital Fund
Bright Capital is an independent venture capital firm that invests globally in a wide range of promising companies, with a focus on energy and resource efficiency, green technology, and industrial biotech. They operate as a merchant venturing entity, building bridges between the US, Russia & CIS, Europe, Middle East, and South Eastern Asia.
Guard Capital
Guard Capital invests in rapidly growing Russian internet companies in their expansion stage, focusing on telecom and internet projects with investments ranging from $1 to $5 million. They leverage intellectual capital and entrepreneurial experience to achieve outstanding results, with a portfolio including businesses like Level Travel and YClients.
The Aurora Funds
The Aurora Funds is a venture capital firm providing capital, connections, and strategic guidance to early-stage healthcare and information technology companies. Founded in 1994, they manage over $234 million across five venture funds and possess extensive venture capital investing and operational experience.
What's next for Doctor At Work?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth phase for Doctor At Work. This capital infusion is likely to fuel further development of its communication tools, expansion into new markets, and enhancement of its analytical capabilities. The company's focus on connecting healthcare professionals and pharmaceutical companies positions it to capitalize on the increasing digitization of the healthcare industry. Future strategies may involve deepening engagement with its existing user base of doctors and pharmacists, as well as forging new partnerships with pharmaceutical firms seeking to leverage its unique platform for targeted outreach and market intelligence. The sustained backing suggests a clear path towards scaling operations and solidifying its market leadership.
See full Doctor At Work company page
